Basel Medical Correlations

BMGL Stock   2.40  0.40  14.29%   
The current 90-days correlation between Basel Medical Group and Levi Strauss Co is -0.19 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Basel Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Basel Medical Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Basel Medical Correlation With Market

Significant diversification

The correlation between Basel Medical Group and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Basel Medical Group and DJI in the same portfolio, assuming nothing else is changed.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Basel Medical Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Moving against Basel Stock

  0.54OM Outset MedicalPairCorr
  0.5ENSG Ensign Group Earnings Call This WeekPairCorr
  0.47DH Definitive HealthcarePairCorr
  0.44VNRX VolitionrxPairCorr
  0.43DXCM DexCom Inc Earnings Call This WeekPairCorr
  0.42FIGS Figs IncPairCorr
  0.38LH Laboratory Earnings Call This WeekPairCorr
  0.37EW Edwards Lifesciences Corp Earnings Call TomorrowPairCorr
  0.54NAKA Kindly MD, Symbol ChangePairCorr
  0.44A Agilent TechnologiesPairCorr
  0.43VANI Vivani MedicalPairCorr
  0.42MDAI Spectral AIPairCorr
  0.4NEUE NeueHealthPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Basel Stock performing well and Basel Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Basel Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.